Publications by authors named "Habip Gedik"

Claim this Profile
T
The Influence of Characteristics and Indexes (NLR, PNI, and SII) Evaluated at Admission on the Mortality Prediction of Infectious Endocarditis Patients.
Aysegul Inci Sezen, Yusuf Emre Ozdemir, Deniz Borcak, Busra Nur Goklu, Zeynep Bilgin, Habip Gedik

Int J Gen Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pylephlebitis: A Rare but Redoubtable Complication of Intra-Abdominal Infections-A Series of 15 Cases.
Serban Nicolae Benea, Teodora Deaconu, Dragos Florea, Ruxandra Moroti, Gabriela Oprica, Habip Gedik

Life (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the long-term outcomes of patients with hepatitis delta.
Muhammet Salih Tarhan, Habip Gedik, Kadriye Kart-Yasar

J Infect Dev Ctries· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life evaluation of incidence and clinical outcomes of COVID-19 among healthcare workers during pre-vaccination and post-vaccination periods: A cross-sectional impact study.
Yusuf Emre Ozdemir, Aysegul Inci Sezen, Serkan Surme, Sevtap Senoglu, Zuhal Yesilbag, Habip Gedik

J Infect Dev Ctries· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of clinical outcomes of vaccinated and unvaccinated patients with hospitalization for COVID-19.
Yusuf Emre Ozdemir, Burak Kizilcay, Muge Sonmezisik, Muhammet Salih Tarhan, Deniz Borcak, Habip Gedik

Acta Microbiol Immunol Hung· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary partial response with tenofovir monotherapy: two adults and one child.
Habip Gedik

J Infect Dev Ctries· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The partial virological response to Tenofovir monotherapy in naive patients with chronic hepatitis B.
Habip Gedik, Muge Sonmezisik

J Pak Med Assoc· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Risk Factors for Mortality in Febrile Neutropenia.
Sabahat Ceken, Habip Gedik, Gulsen Iskender, Meryem Demirelli, Duygu Mert

J Infect Dev Ctries· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for bloodstream infections due to extended-spectrum β-lactamase producing Enterobacteriaceae in cancer patients.
Sabahat Ceken, Gulsen Iskender, Habip Gedik, Fazilet Duygu, Duygu Mert

J Infect Dev Ctries· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Jak-2 mutation frequency in patients with thrombocytosis.
Osman Yokus, Habip Gedik

Caspian J Intern Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could Neutrophil CD64 Expression Be Used as a Diagnostic Parameter of Bacteremia in Patients with Febrile Neutropenia?
Nur Efe İris, Taner Yıldırmak, Habip Gedik, Funda Şimşek, Demet Aydın

Turk J Haematol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis.
Oren Zusman, Sergey Altunin, Fidi Koppel, Yael Dishon Benattar, Habip Gedik

J Antimicrob Chemother· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Janus kinase 2 mutations in cases with BCR-ABL-negative chronic myeloproliferative disorders from Turkey.
Ismail Yildiz, Osman Yokuş, Habip Gedik

Avicenna J Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic resistance status and its costs in hematological patients: A two-year analysis.
Habip Gedik

Caspian J Intern Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cross-sectional evaluation of home health service in patients with chronic neurologic diseases in a province of Turkey.
Songul Senadim, Murat Cabalar, Habip Gedik, Ali Bayram Kasim, Anıl Bulut

Acta Neurol Belg· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etiological causes of pancytopenia: A report of 137 cases.
Osman Yokuş, Habip Gedik

Avicenna J Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis.
Habip Gedik

Clinicoecon Outcomes Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel antifungal drugs against fungal pathogens: do they provide promising results for treatment?
Habip Gedik, Funda Şimşek, Taner Yıldırmak, Arzu Kantürk, Deniz Arıca

Indian J Hematol Blood Transfus· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which Multidrug-Resitant Bacteria are Emerging in Patients with Hematological Malignancies?: One-Year Report.
Habip Gedik, Funda Şimşek, Taner Yıldırmak, Arzu Kantürk, Demet Aydın

Indian J Hematol Blood Transfus· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.
Habip Gedik, Funda Şimşek, Arzu Kantürk, Taner Yıldırmak, Deniz Arıca

Afr Health Sci· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community-acquired intracranial suppurative infections: A 15-year report.
Taner Yıldırmak, Habip Gedik, Funda Simşek, Arzu Kantürk

Surg Neurol Int· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.
Habip Gedik, Taner Yıldırmak, Funda Simşek, Arzu Kantürk, Deniz Arıca

J Infect Dev Ctries· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bloodstream infections in patients with hematological malignancies: which is more fatal - cancer or resistant pathogens?
Habip Gedik, Funda Simşek, Arzu Kantürk, Taner Yildirmak, Deniz Arica

Ther Clin Risk Manag· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage.
Habip Gedik, Funda Simşek, Taner Yıldırmak, Arzu Kantürk, Deniz Arıca

Ther Clin Risk Manag· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Money and transmission of bacteria.
Habip Gedik, Timothy A Voss, Andreas Voss

Antimicrob Resist Infect Control· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis